Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Mirabegron well tolerated and improves overactive bladder variables in large study

April 19, 2010

Clinical data disclosed on avosentan in overt diabetic nephropathy

April 14, 2010

Allergan and Serenity Pharmaceuticals to collaborate on development Ser-120 for nocturia

April 8, 2010

Nymox outlines new plans for phase III BPH drug NX-1207

April 7, 2010

GSK's Duodart approved for benign prostatic hyperplasia in E.U.

April 6, 2010

Action Pharma completes dosing in phase II AP-214 trial

April 1, 2010

GLY-230 may ameliorate renal disease in patients with diabetes

April 1, 2010

GSK obtains Swiss approval for Duodart in benign prostatic hyperplasia

March 24, 2010

Paricalcitol improves albuminuria in diabetic nephropathy

March 16, 2010

Bupivacaine alleviates bladder syndrome/interstitial cystitis pain in lidocaine-refractory patients

March 8, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...